MARKET

MDGL

MDGL

Madrigal Pharmac
NASDAQ
251.63
+15.43
+6.53%
After Hours: 253.84 +2.21 +0.88% 18:39 03/01 EST
OPEN
237.38
PREV CLOSE
236.20
HIGH
252.50
LOW
237.33
VOLUME
459.35K
TURNOVER
0
52 WEEK HIGH
322.67
52 WEEK LOW
119.76
MARKET CAP
5.01B
P/E (TTM)
-12.5857
1D
5D
1M
3M
1Y
5Y
Oppenheimer Maintains Outperform on Madrigal Pharmaceuticals, Raises Price Target to $320
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Moderna (MRNA) and Madrigal Pharmaceuticals (MDGL)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Alcon (ALC) and Sarepta Therapeutics (SRPT)
TipRanks · 2d ago
Notable Thursday Option Activity: MDGL, AMWD, SAIA
NASDAQ · 2d ago
Buy Rating for Madrigal Pharmaceuticals Amidst Strong Clinical and Financial Prospects
TipRanks · 3d ago
Buy Rating Affirmed for Madrigal Pharmaceuticals Amid Strong Drug Approval Prospects and Solid Financials
TipRanks · 3d ago
Madrigal Pharmaceuticals: Q4 Earnings Insights
Madrigal Pharmaceuticals reported its Q4 earnings on February 28. The company missed estimates by 8.0% and missed revenue by $0. Madrigal pharmaceuticals is expected to announce its earnings Wednesday morning. The stock is currently trading at $5.68.
Benzinga · 3d ago
More
About MDGL
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-B (THR-B), agonist being developed as a once-daily oral pill for the treatment of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). NASH is a liver disease that affects people with metabolic diseases, such as obesity and diabetes and non-alcoholic fatty liver disease (NAFLD).

Webull offers Madrigal Pharmaceuticals Inc stock information, including NASDAQ: MDGL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDGL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDGL stock methods without spending real money on the virtual paper trading platform.